APA (7th ed.) Citation

Phyo, A. P., Jittamala, P., Nosten, F. H., Pukrittayakamee, S., Imwong, M., White, N. J., . . . Möhrle, J. J. (2016). Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: An open-label phase 2 trial. Lancet Infectious Diseases, 16(1), 61. https://doi.org/10.1016/S1473-3099(15)00320-5

Chicago Style (17th ed.) Citation

Phyo, Aung Pyae, et al. "Antimalarial Activity of Artefenomel (OZ439), a Novel Synthetic Antimalarial Endoperoxide, in Patients with Plasmodium Falciparum and Plasmodium Vivax Malaria: An Open-label Phase 2 Trial." Lancet Infectious Diseases 16, no. 1 (2016): 61. https://doi.org/10.1016/S1473-3099(15)00320-5.

MLA (9th ed.) Citation

Phyo, Aung Pyae, et al. "Antimalarial Activity of Artefenomel (OZ439), a Novel Synthetic Antimalarial Endoperoxide, in Patients with Plasmodium Falciparum and Plasmodium Vivax Malaria: An Open-label Phase 2 Trial." Lancet Infectious Diseases, vol. 16, no. 1, 2016, p. 61, https://doi.org/10.1016/S1473-3099(15)00320-5.